These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30714667)

  • 1. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.
    de Boer RA; De Keulenaer G; Bauersachs J; Brutsaert D; Cleland JG; Diez J; Du XJ; Ford P; Heinzel FR; Lipson KE; McDonagh T; Lopez-Andres N; Lunde IG; Lyon AR; Pollesello P; Prasad SK; Tocchetti CG; Mayr M; Sluijter JPG; Thum T; Tschöpe C; Zannad F; Zimmermann WH; Ruschitzka F; Filippatos G; Lindsey ML; Maack C; Heymans S
    Eur J Heart Fail; 2019 Mar; 21(3):272-285. PubMed ID: 30714667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
    van Bilsen M; Patel HC; Bauersachs J; Böhm M; Borggrefe M; Brutsaert D; Coats AJS; de Boer RA; de Keulenaer GW; Filippatos GS; Floras J; Grassi G; Jankowska EA; Kornet L; Lunde IG; Maack C; Mahfoud F; Pollesello P; Ponikowski P; Ruschitzka F; Sabbah HN; Schultz HD; Seferovic P; Slart RHJA; Taggart P; Tocchetti CG; Van Laake LW; Zannad F; Heymans S; Lyon AR
    Eur J Heart Fail; 2017 Nov; 19(11):1361-1378. PubMed ID: 28949064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives.
    González A; Schelbert EB; Díez J; Butler J
    J Am Coll Cardiol; 2018 Apr; 71(15):1696-1706. PubMed ID: 29650126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
    Čelutkienė J; Plymen CM; Flachskampf FA; de Boer RA; Grapsa J; Manka R; Anderson L; Garbi M; Barberis V; Filardi PP; Gargiulo P; Zamorano JL; Lainscak M; Seferovic P; Ruschitzka F; Rosano GMC; Nihoyannopoulos P
    Eur J Heart Fail; 2018 Dec; 20(12):1615-1633. PubMed ID: 30411833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix fibrotic markers in heart failure.
    Zannad F; Rossignol P; Iraqi W
    Heart Fail Rev; 2010 Jul; 15(4):319-29. PubMed ID: 19404737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    de Boer RA; Hulot JS; Tocchetti CG; Aboumsallem JP; Ameri P; Anker SD; Bauersachs J; Bertero E; Coats AJS; Čelutkienė J; Chioncel O; Dodion P; Eschenhagen T; Farmakis D; Bayes-Genis A; Jäger D; Jankowska EA; Kitsis RN; Konety SH; Larkin J; Lehmann L; Lenihan DJ; Maack C; Moslehi JJ; Müller OJ; Nowak-Sliwinska P; Piepoli MF; Ponikowski P; Pudil R; Rainer PP; Ruschitzka F; Sawyer D; Seferovic PM; Suter T; Thum T; van der Meer P; Van Laake LW; von Haehling S; Heymans S; Lyon AR; Backs J
    Eur J Heart Fail; 2020 Dec; 22(12):2272-2289. PubMed ID: 33094495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.
    Hohl M; Ardehali H; Azuaje FJ; Breckenridge RA; Doehner W; Eaton P; Ehret GB; Fujita T; Gaetani R; Giacca M; Hasenfuß G; Heymans S; Leite-Moreira AF; Linke WA; Linz D; Lyon A; Mamas MA; Orešič M; Papp Z; Pedrazzini T; Piepoli M; Prosser B; Rizzuto R; Tarone G; Tian R; van Craenenbroeck E; van Rooij E; Wai T; Weiss G; Maack C
    Eur J Heart Fail; 2014 Jan; 16(1):6-14. PubMed ID: 24453095
    [No Abstract]   [Full Text] [Related]  

  • 9. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.
    Farris SD; Don C; Helterline D; Costa C; Plummer T; Steffes S; Mahr C; Mokadam NA; Stempien-Otero A
    J Am Coll Cardiol; 2017 Jul; 70(3):344-354. PubMed ID: 28705316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    Harjola VP; Mullens W; Banaszewski M; Bauersachs J; Brunner-La Rocca HP; Chioncel O; Collins SP; Doehner W; Filippatos GS; Flammer AJ; Fuhrmann V; Lainscak M; Lassus J; Legrand M; Masip J; Mueller C; Papp Z; Parissis J; Platz E; Rudiger A; Ruschitzka F; Schäfer A; Seferovic PM; Skouri H; Yilmaz MB; Mebazaa A
    Eur J Heart Fail; 2017 Jul; 19(7):821-836. PubMed ID: 28560717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.
    Suthahar N; Meijers WC; Silljé HHW; de Boer RA
    Curr Heart Fail Rep; 2017 Aug; 14(4):235-250. PubMed ID: 28707261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.
    Maack C; Lehrke M; Backs J; Heinzel FR; Hulot JS; Marx N; Paulus WJ; Rossignol P; Taegtmeyer H; Bauersachs J; Bayes-Genis A; Brutsaert D; Bugger H; Clarke K; Cosentino F; De Keulenaer G; Dei Cas A; González A; Huelsmann M; Iaccarino G; Lunde IG; Lyon AR; Pollesello P; Rena G; Riksen NP; Rosano G; Staels B; van Laake LW; Wanner C; Farmakis D; Filippatos G; Ruschitzka F; Seferovic P; de Boer RA; Heymans S
    Eur Heart J; 2018 Dec; 39(48):4243-4254. PubMed ID: 30295797
    [No Abstract]   [Full Text] [Related]  

  • 14. Epigenetic regulation of cardiac fibrosis.
    Stratton MS; McKinsey TA
    J Mol Cell Cardiol; 2016 Mar; 92():206-13. PubMed ID: 26876451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
    Gorter TM; van Veldhuisen DJ; Bauersachs J; Borlaug BA; Celutkiene J; Coats AJS; Crespo-Leiro MG; Guazzi M; Harjola VP; Heymans S; Hill L; Lainscak M; Lam CSP; Lund LH; Lyon AR; Mebazaa A; Mueller C; Paulus WJ; Pieske B; Piepoli MF; Ruschitzka F; Rutten FH; Seferovic PM; Solomon SD; Shah SJ; Triposkiadis F; Wachter R; Tschöpe C; de Boer RA
    Eur J Heart Fail; 2018 Jan; 20(1):16-37. PubMed ID: 29044932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
    Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
    J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy.
    Sharim J; Daniels LB
    Curr Cardiol Rep; 2020 May; 22(6):41. PubMed ID: 32430626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology.
    Moura B; Aimo A; Al-Mohammad A; Flammer A; Barberis V; Bayes-Genis A; Brunner-La Rocca HP; Fontes-Carvalho R; Grapsa J; Hülsmann M; Ibrahim N; Knackstedt C; Januzzi JL; Lapinskas T; Sarrias A; Matskeplishvili S; Meijers WC; Messroghli D; Mueller C; Pavo N; Simonavičius J; Teske AJ; van Kimmenade R; Seferovic P; Coats AJS; Emdin M; Richards AM
    Eur J Heart Fail; 2021 Oct; 23(10):1577-1596. PubMed ID: 34482622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial fibrosis: biomedical research from bench to bedside.
    Gyöngyösi M; Winkler J; Ramos I; Do QT; Firat H; McDonald K; González A; Thum T; Díez J; Jaisser F; Pizard A; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):177-191. PubMed ID: 28157267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment.
    Ravassa S; González A; Bayés-Genís A; Lupón J; Díez J
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):248-254. PubMed ID: 31759935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.